2-Chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)benzamide

Catalog No.: 
ACIVQK844
CAS No.: 
1172238-65-1
Molecular Formula: 
C12H12ClN3O2
Molecular Weight: 
265.70
2-Chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$116.00InquiryInquiry
5g95%$522.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)benzamide
IUPAC Name2-chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)benzamide
MDL No.MFCD09865002
Molecular FormulaC12H12ClN3O2
Molecular Weight265.70
SMILESO=C(NCCO)C1=CC=C(N2N=CC=C2)C=C1Cl
InChI KeyGSAZJKOCCNFENH-UHFFFAOYSA-N
Synonym2-chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)benzamide;2-chloro-N-(2-hydroxyethyl)-4-pyrazol-1-ylbenzamide;Benzamide, 2-chloro-N-(2-hydroxyethyl)-4-(1H-pyrazol-1-yl)-
CAS No.1172238-65-1

Synthetic Route by SureRoute

1. ACIVQK844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6In Stock
  2. Plus
  3. ACVFJZ920 route compound structure diagram
    ACVFJZ920313674-12-3In Stock
  4. Then
  5. ACIVQK844 route product structure diagram
    ACIVQK8441172238-65-1
Inquiry

2. ACIVQK844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6In Stock
  4. Then
  5. ACIVQK844 route product structure diagram
    ACIVQK8441172238-65-1
Inquiry

3. ACIVQK844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVQK844 route product structure diagram
    ACIVQK8441172238-65-1
Inquiry

Comments (0)